The Food and Drug Administration has approved a treatment for dermatitis made by Perrigo under a collaboration with Chicago-based Cobrek Pharmaceutical.

Mylan will be banned temporarily from launching a generic drug for acne pending a federal court's decision whether or not to bar it, according to published reports.

Hi-Tech Pharmacal has acquired marketing and distribution rights for a product designed to treat coughs and upper respiratory symptoms associated with an allergy or a cold.

The final outcome of the battle between Israel’s Teva Pharmaceutical Industries and Canada’s Valeant Pharmaceuticals International to buy Cephalon serves as a good illustration of why it helps to have a plan B.



Dispensing narcotics and other highly abused prescription drugs, pharmacies have always been potential targets for robbery and burglary. But a series of violent crimes over the past year and a half have thrown a spotlight on the dangers faced by pharmacy workers and customers, and have galvanized public opinion for tougher laws.


Prasco will market an authorized generic drug for urinary tract infections under an agreement with Shionogi, the company said Monday.

Generic drug maker Sagent Pharmaceuticals has launched a new drug for neuromuscular disorders, the company said.

With the global biosimilars market expected to expand nearly sixfold by the middle of the decade, market research firm IMS Health is launching a market-measurement tool for drug makers interested in getting into the space, the company said.

Hospira has appointed Abbott executive William Dempsey to its board.

Generic drug maker Perrigo reported sales of $2.76 billion and profits of $341 million in fiscal year 2011, according to an earnings report released Tuesday.

Pfizer announced that the patent for its popular erectile dysfunction treatment was upheld in court.

Lannett announced that it has started shipping morphine sulfate oral solution, a painkiller approved by the Food and Drug Administration in June.